PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM A LARGE, RANDOMIZED CONTROLLED STUDY WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR CHRONIC HEPATITIS B (CHB)


Chan H. L. , Ahn S. H. , Chuang W. L. , Hui A. J. , Tabak F. , Mehta R., ...Daha Fazla

50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Avusturya, 22 - 26 Nisan 2015, cilt.62 identifier